Catafast 50 mg 9 sachets

Tradename

Catafast

Composition

Each sachet contains:

Diclofenac 50 mg

Auxiliary components:

Potassium hydrogen carbonate, mannitol, aspartame, sodium saccharin, sucrose, mint flavor.

Properties

NSAID, a derivative of phenylacetic acid. It has a pronounced analgesic, anti-inflammatory and antipyretic effect. Due to its rapid onset of action, the use of diclofenac potassium salt is preferred for the treatment of acute pain and inflammatory conditions.

The main mechanism of action of diclofenac is the inhibition of the synthesis of prostaglandins, which play an important role in the pathogenesis of inflammation, pain and fever.

In vitro, diclofenac potassium at concentrations equivalent to those achieved in the treatment of patients does not inhibit the biosynthesis of proteoglycans in cartilage tissue.

Indications

For short-term treatment of the following acute conditions: post-traumatic pain, inflammation and swelling, for example, due to damage to the ligaments; postoperative pain, inflammation and swelling, for example, after dental or orthopedic surgery; pain and / or inflammation accompanying gynecological diseases, for example, primary dysmenorrhea or adnexitis; headache, migraine attacks; toothache; pain syndromes from the spine; pain in muscles and joints; neuralgia; rheumatic diseases of extra-articular soft tissues; proctitis; renal colic; biliary colic; as an adjuvant in infectious and inflammatory diseases of the ear, throat and nose, for example, pharyngotonsillitis, otitis media, accompanied by severe pain and inflammation.

Method of administration and dosage:

The optimal dosage regimen is determined by the doctor. The compliance of the used dosage form of a particular drug with indications fo use and dosage regimen should be strictly observed.

Contraindications

Hypersensitivity (including to other NSAlDs); attacks of bronchial asthma, urticaria or acute rhinitis in history caused by taking acetylsalicylic acid or other NSAlDs; peptic ulcer or intestinal ulcer in the acute phase; ulcerative bleeding or perforation; inflammatory bowel disease (Crohn’s disease, ulcerative colitis) in the acute phase; severe liver failure; active liver disease; severe renal failure (CC less than 30 ml / min); progressive kidney disease; confirmed hyperkalemia; severe heart failure; period after coronary artery bypass grafting; disorders of hematopoiesis; various disorders of hemost (including hemophilia); Ill trimester of pregnancy; lactation period; children under 14 years of age.

Precautions:

Special care should be taken when using diclofenac potassium in patients receiving drugs that increase the risk of gastrointestinal bleeding: systemic corticosteroids, anticoagulants, antiplatelet agents or selective serotonin reuptake inhibitors.

Side effects

From the nervous system: often — headache dizziness; rarely — drowsiness;

On the part of the organ of hearing and labyrinth disorders: often — vertigo; very rarely — hearing impairment, tinnitus.

From the digestive system: often — dry mouth, abdominal pain, nausea, vomiting, belching, heartburn, diarrhea, dyspepsia, flatulence, anorexia, increased activity of hepatic transferases in the blood serum; infrequently decreased appetite, anorexia.